Maximiliano Matus-Köhler , Pablo Araya-Vega , Sergio Mella , Alejandro Aguayo-Reyes , Mario Quezada-Aguiluz , Néstor Herrera-Chávez , Felipe Morales-León , Gerardo González-Rocha , Andrés Opazo-Capurro
{"title":"智利首例产imp -13的耐碳青霉烯类铜绿假单胞菌ST313/ExoU+/O1分离株的基因组特征","authors":"Maximiliano Matus-Köhler , Pablo Araya-Vega , Sergio Mella , Alejandro Aguayo-Reyes , Mario Quezada-Aguiluz , Néstor Herrera-Chávez , Felipe Morales-León , Gerardo González-Rocha , Andrés Opazo-Capurro","doi":"10.1016/j.jgar.2025.05.016","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Carbapenemase-resistant <em>Pseudomonas aeruginosa</em> (CR-PA) is a WHO priority pathogen posing a serious public health threat. This study reports the first IMP-13-producing <em>P. aeruginosa</em> isolate (150UDEC/24) in Chile, recovered from a bone infection in April 2024.</div></div><div><h3>Methods</h3><div>Antimicrobial susceptibility was determined using disk diffusion and MIC strip tests. Whole-genome sequencing (WGS) was performed on the Illumina NovaSeq platform, and annotation by the NCBI PGAP. Analyses included Staramr, VFDB, MLST, PAst, MOB-Typer, MOB-Recon, and Integron Finder2. Phylogenetic analysis of 150UDEC/24 and 44 ST313 genomes was carried out by IQTree and iTOL for visualization.</div></div><div><h3>Results</h3><div>The 150UDEC/24 isolate exhibited resistance to relevant antibiotics, including cephalosporins and carbapenems (imipenem, meropenem). It belonged to sequence type (ST) ST313 and serotype O1 and harboured multiple resistance genes: <em>aph(6)-Id, aph(3′’)-Ib, aph(3′)-IIb, aac(6′)-Ib4, aph(3′)-VI, catB7, dfrB3, sul1, fosA, bla</em><sub>OXA-488</sub><em>, bla</em><sub>OXA-2</sub><em>, bla</em><sub>PDC-37</sub><em>,</em> and <em>bla</em><sub>IMP-13</sub>. The <em>bla</em><sub>IMP-13</sub> gene was embedded in a class 1 integron alongside <em>dfrB3, aac(6′)-Ib4,</em> and <em>bla</em><sub>OXA-2</sub>. Additionally, the virulence gene <em>exoU</em> was detected. Phylogenetic analysis showed 150UDEC/24 diverged from other ST313 strains, with no other isolate carrying <em>bla</em><sub>IMP-13</sub>, suggesting distinct evolution.</div></div><div><h3>Conclusions</h3><div>This study provides the first genomic characterization of an IMP-13-producing ST313 carbapenem-resistant <em>P. aeruginosa</em> isolate (150UDEC/24) in Chile, containing multiple resistance genes and the ExoU virulence factor. Phylogenetic analysis suggests unique evolution, emphasizing the need for continued genomic surveillance to monitor the emergence of highly resistant, virulent strains in clinical settings.</div></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"44 ","pages":"Pages 8-11"},"PeriodicalIF":3.2000,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Genomic characterisation of the first case of IMP-13-producing carbapenem-resistant Pseudomonas aeruginosa ST313/ExoU+/O1 isolate in Chile\",\"authors\":\"Maximiliano Matus-Köhler , Pablo Araya-Vega , Sergio Mella , Alejandro Aguayo-Reyes , Mario Quezada-Aguiluz , Néstor Herrera-Chávez , Felipe Morales-León , Gerardo González-Rocha , Andrés Opazo-Capurro\",\"doi\":\"10.1016/j.jgar.2025.05.016\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>Carbapenemase-resistant <em>Pseudomonas aeruginosa</em> (CR-PA) is a WHO priority pathogen posing a serious public health threat. This study reports the first IMP-13-producing <em>P. aeruginosa</em> isolate (150UDEC/24) in Chile, recovered from a bone infection in April 2024.</div></div><div><h3>Methods</h3><div>Antimicrobial susceptibility was determined using disk diffusion and MIC strip tests. Whole-genome sequencing (WGS) was performed on the Illumina NovaSeq platform, and annotation by the NCBI PGAP. Analyses included Staramr, VFDB, MLST, PAst, MOB-Typer, MOB-Recon, and Integron Finder2. Phylogenetic analysis of 150UDEC/24 and 44 ST313 genomes was carried out by IQTree and iTOL for visualization.</div></div><div><h3>Results</h3><div>The 150UDEC/24 isolate exhibited resistance to relevant antibiotics, including cephalosporins and carbapenems (imipenem, meropenem). It belonged to sequence type (ST) ST313 and serotype O1 and harboured multiple resistance genes: <em>aph(6)-Id, aph(3′’)-Ib, aph(3′)-IIb, aac(6′)-Ib4, aph(3′)-VI, catB7, dfrB3, sul1, fosA, bla</em><sub>OXA-488</sub><em>, bla</em><sub>OXA-2</sub><em>, bla</em><sub>PDC-37</sub><em>,</em> and <em>bla</em><sub>IMP-13</sub>. The <em>bla</em><sub>IMP-13</sub> gene was embedded in a class 1 integron alongside <em>dfrB3, aac(6′)-Ib4,</em> and <em>bla</em><sub>OXA-2</sub>. Additionally, the virulence gene <em>exoU</em> was detected. Phylogenetic analysis showed 150UDEC/24 diverged from other ST313 strains, with no other isolate carrying <em>bla</em><sub>IMP-13</sub>, suggesting distinct evolution.</div></div><div><h3>Conclusions</h3><div>This study provides the first genomic characterization of an IMP-13-producing ST313 carbapenem-resistant <em>P. aeruginosa</em> isolate (150UDEC/24) in Chile, containing multiple resistance genes and the ExoU virulence factor. Phylogenetic analysis suggests unique evolution, emphasizing the need for continued genomic surveillance to monitor the emergence of highly resistant, virulent strains in clinical settings.</div></div>\",\"PeriodicalId\":15936,\"journal\":{\"name\":\"Journal of global antimicrobial resistance\",\"volume\":\"44 \",\"pages\":\"Pages 8-11\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2025-05-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of global antimicrobial resistance\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2213716525001201\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of global antimicrobial resistance","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213716525001201","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Genomic characterisation of the first case of IMP-13-producing carbapenem-resistant Pseudomonas aeruginosa ST313/ExoU+/O1 isolate in Chile
Objective
Carbapenemase-resistant Pseudomonas aeruginosa (CR-PA) is a WHO priority pathogen posing a serious public health threat. This study reports the first IMP-13-producing P. aeruginosa isolate (150UDEC/24) in Chile, recovered from a bone infection in April 2024.
Methods
Antimicrobial susceptibility was determined using disk diffusion and MIC strip tests. Whole-genome sequencing (WGS) was performed on the Illumina NovaSeq platform, and annotation by the NCBI PGAP. Analyses included Staramr, VFDB, MLST, PAst, MOB-Typer, MOB-Recon, and Integron Finder2. Phylogenetic analysis of 150UDEC/24 and 44 ST313 genomes was carried out by IQTree and iTOL for visualization.
Results
The 150UDEC/24 isolate exhibited resistance to relevant antibiotics, including cephalosporins and carbapenems (imipenem, meropenem). It belonged to sequence type (ST) ST313 and serotype O1 and harboured multiple resistance genes: aph(6)-Id, aph(3′’)-Ib, aph(3′)-IIb, aac(6′)-Ib4, aph(3′)-VI, catB7, dfrB3, sul1, fosA, blaOXA-488, blaOXA-2, blaPDC-37, and blaIMP-13. The blaIMP-13 gene was embedded in a class 1 integron alongside dfrB3, aac(6′)-Ib4, and blaOXA-2. Additionally, the virulence gene exoU was detected. Phylogenetic analysis showed 150UDEC/24 diverged from other ST313 strains, with no other isolate carrying blaIMP-13, suggesting distinct evolution.
Conclusions
This study provides the first genomic characterization of an IMP-13-producing ST313 carbapenem-resistant P. aeruginosa isolate (150UDEC/24) in Chile, containing multiple resistance genes and the ExoU virulence factor. Phylogenetic analysis suggests unique evolution, emphasizing the need for continued genomic surveillance to monitor the emergence of highly resistant, virulent strains in clinical settings.
期刊介绍:
The Journal of Global Antimicrobial Resistance (JGAR) is a quarterly online journal run by an international Editorial Board that focuses on the global spread of antibiotic-resistant microbes.
JGAR is a dedicated journal for all professionals working in research, health care, the environment and animal infection control, aiming to track the resistance threat worldwide and provides a single voice devoted to antimicrobial resistance (AMR).
Featuring peer-reviewed and up to date research articles, reviews, short notes and hot topics JGAR covers the key topics related to antibacterial, antiviral, antifungal and antiparasitic resistance.